在多种原发性肺癌的新辅助化疗免疫治疗反应中,多种AT2细胞周围的AT2细胞阻碍了三级淋巴体结构的功能
Wenxiang Wang1,2,3, Sida Cheng1, Hongchengcheng Chen1
1Department of Thoracic Surgery, Peking University People's Hospital, Beijing, Beijing, China.
Journal for immunotherapy of cancer
|October 8, 2025
概括
在多重原发性肺癌 (MPLC) 中,非响应性病变中的II型膜上皮细胞 (AT2) 通过MIF-SIAE通路抑制三级淋巴体结构 (TLS) 内的B细胞,阻碍免疫治疗的有效性.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 在多重原发性肺癌 (MPLC) 病变中免疫疗法反应不一致,这构成了治疗挑战.
- 了解各种反应背后的机制对于改善患者的治疗结果至关重要.
研究的目的:
- 在MPLC中调查具有差异性免疫疗法反应的病变的多组景观.
- 阐明导致治疗耐药性的细胞和分子相互作用.
主要方法:
- 来自MPLC患者的病变的综合多组学分析.
- 外部单细胞数据和多重免疫组织化学验证.
- 细胞邻居和空间同居化分析.
主要成果:
- 在所有结节中存在的三级淋巴体结构 (TLS),在不响应的结节中可能受损.
- 第二种类型的膜上皮细胞 (AT2) 阳性邻居与不响应相关.
- AT2细胞通过巨细胞迁移抑制因子 (MIF) -酸乙雌激酶 (SIAE) 轴在TLS内的B细胞上调节免疫抑制标记物.
结论:
- 通过MPLC中的MIF-SIAE信号轴,AT2细胞通过抑制TLS内的B细胞来施加免疫抑制.
- 这种机制为开发针对MPLC患者量身定制的免疫疗法提供了新的见解.
更多相关视频
08:32Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors
Published on: June 7, 2018
10.3K
07:45Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8+ T Cells During LN Metastasis
Published on: January 26, 2024
2.7K
相关概念视频
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
